BioNxt Solutions Issues New Stock Options

BioNxt Solutions Inc., a bioscience company, has announced the granting of a total of 750,000 stock options under their stock option plan. These options, awarded to certain insiders, consultants, and an employee, can be exercised to acquire common shares at a price of $0.33 over a three-year period. These options vested immediately.

Moreover, the company granted an additional 2,650,000 options. These also allow acquisition of common shares at $0.33 but over a five-year span. Immediate vesting applies here as well. The option plan had received shareholder approval on November 7, 2025.

Per Canadian Securities Exchange policies, both the options and any resulting common shares will be subject to a four-month hold period.